STATE-OF-THE-ART ANTIMICROBIALS
Abstract
Currently, one of the priorities of the World Health Organization is antibiotic-resistant bacteria. Bacteria have a great capacity for dissemination and make it difficult to treat infectious diseases. It is known that they have high morbidity and mortality worldwide, which is considered a global public health problem. The objective is to carry out a documentary review of the latest generation antimicrobials, which may constitute a therapeutic alternative. An analysis of the information available and documented in the scientific literature consulted was carried out. The sampling was carried out between the years 2015-2022, to cover the last years. Google academic, PubMed and MDPI search engines were used as an infotechnology tool. At present there are new antibiotic alternatives among which are Ceftolozano-tazobactam, Ceftazidime-avibactam, Ceftaroline, Ceftobiprole, Dalbavancin, Telavancin, Tedizolid, Omadacycline, Delafloxacin and Lefamulin. Also, the use of peptides that have activity against bacterial, fungal or viral infections was confirmed, as well as bacteriophages that different studies have shown the efficacy of phage therapy against infections. In recent years, the scientific community has been attracted by the so-called photothermal therapy to combat pathogens (nanomaterials and metals), plant-derived antimicrobials and other advances such as bisphocins and hydrogels that can be used in the treatment of infections caused by antibiotic resistant bacteria. It is concluded that there are state-of-the-art antimicrobials that could be part, now or in the future, of a new therapeutic arsenal
Downloads
![](https://revista.cnic.cu/public/journals/1/article_4047_cover_es_ES.jpg)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Copyright (c) 2023 Revista CENIC Ciencias Químicas
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en esta revista están de acuerdo con los siguientes términos:
Los autores conservan los derechos de autor y garantizan a la revista el derecho de ser la primera publicación del trabajo al igual que licenciado bajo una Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista.
Los autores pueden establecer por separado acuerdos adicionales para la distribución no exclusiva de la versión de la obra publicada en la revista (por ejemplo, situarlo en un repositorio institucional o publicarlo en un libro), con un reconocimiento de su publicación inicial en esta revista.
Se permite y se anima a los autores a difundir sus trabajos electrónicamente (por ejemplo, en repositorios institucionales o en su propio sitio web) antes y durante el proceso de envío, ya que puede dar lugar a intercambios productivos, así como a una citación más temprana y mayor de los trabajos publicados (Véase The Effect of Open Access) (en inglés).